Trial Dataset: Single-day Intravenous Fosaprepitant versus 3-day oral Aprepitant anti-emetic regimen in pediatric patients receiving highly-emetogenic chemotherapy: An Investigator-initiated, Randomized, Open-label, Non-inferiority trial (CTRI: REF/2019/05/019082)

This dataset contains the individual patient data of an investigator-initiated non-inferiority trial, which assessed the non-inferiority of intravenous fosaprepitant with respect to oral aprepitant among children receiving highly emetogenic chemotherapy. The trial was conducted at All India Institute of Medical Sciences (AIIMS), New Delhi, India. (Clinical Trial Registry of India Number: CTRI: REF/2019/05/019082 [registered on 13.05.2019])